Defective antigen processing associated with familial disseminated mycobacteriosis

Clinical and Experimental Immunology

Volumn 103, Issue 1, 1996, Pages 35-39

  D'Souza, S ^a,c   Levin, M ^a   Faith, A ^a   Yssel, H ^b   Bennett, B ^b   Lake, R A ^a   Brown, I N ^a   Lamb, J R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MERCK RESEARCH LABORATORIES   (United States)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Antigen processing; Interferon gamma; Mycobacterium avium complex mycobacteria; T cells

Indexed keywords

GAMMA INTERFERON;

ANTIGEN PRESENTATION; ARTICLE; CASE REPORT; CELL LINE; CHILD; CONTROLLED STUDY; HUMAN; IMMUNE DEFICIENCY; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030060445     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.00904.x     Document Type: Article

References (26)

1. Levin M, Newport MJ, D'Souza S et al. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 1995; 345:79-83.
2. Chaisson RH, Hopewell PC. Mycobacteria and AIDS mortality. Ann Rev Respir Dis 1989; 1139:1-3.
3. Ellner J, Goldberger MJ, Parenti DM. Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution. J Infect Dis 1991; 163:1326-35.
4. Murray HW, Scavuzzo D, Jacobs JL et al. In vitro and in vivo activation of human mononuclear phagocytes by interferon-γ. Studies with normal and AIDS monocytes. J Immunol 1987; 138:2457-62.
5. Johnson JL, Shiratsuchi H, Toba H et al. Preservation of monocyte effector functions against Mycobacterium avium-intracellulare in patients with AIDS. Infect Immun 1991; 59:3639-45.
6. Yamamura M, Uyemura K, Deans JR et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254:277-9.
7. Parronchi P, Macchia D, Piccini MR et al. Allergen and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991; 88:4538-42.
8. Collins FM. Mycobacterial disease, immunosuppression, and the acquired immunodeficiency syndrome. Clin Microbiol Rev 1981; 2:360-77.
9. Holland SM, Eisenstein EM, Kuhns DB et al. Treatment of refractory disseminated non-tuberculosis mycobacterial infection with interferon gamma. The N Engl J Med 1994; 330:1348-55.
10. Uchiyama N, Greene GR, Warren BJ. Possible monocyte killing defect in familial atypical mycobacteriosis. J Paed 1981; 98:785-8.
11. Engbaek HC. Three cases in the same family of fatal infection with M avium. Acta Tuberc Scand 1964; 45:105-17.
12. Rothbard JB, Lechler R, Howland K et al. Structural model of HLA-DR restricted T cell antigen recognition. Cell 1988; 52:515-23.
13. Abrams JS, Roncarolo MG, Yssel H et al. Strategies and practice of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 1992; 25:5-30.
14. Favre C, Wijdenes J, Cabrillat H et al. Epitope mapping of recombinant human gamma interferon using monoclonal antibodies. Mol Immunol 1989; 26:17-25.
15. Yssel H, Johnson KE, Schneider PV et al. T cell activation inducing epitopes of the house dust mite allergen Der p I. Induction of a restricted cytokine production profile of Der p I-specific T cell clones upon antigen-specific activation. J Immunol 1992; 148:738-48.
16. Chretien I, Van Kimmenade A, Pearce M et al. Development of polyclonal and monoclonal antibodies for immunoassay and neutralization of human interleukin-4. J Immunol Methods 1989; 117:67-81.
17. + T cell clones from a human chimera IL-5, IL-2, IFN-γ and granulocyte/macrophage-colony-stimulating factor but not IL-4. J Immunol 1990; 144:902-8.
18. Lamb JR, Eckels DD, Lake P et al. Human T cell clones recognize chemically synthesized peptides of influenza haemagglutinin. Nature 1982; 300:66-69.
19. Dalton DK, Pitts-Meek S, Keshav S et al. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 1993; 259:1739-42.
20. Johnson BJ, McMurray DN. Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis infected monocytcs. Infect Immun 1994; 62:1444-50.
21. Buschman E, Taniyama T, Nakamura R et al. Functional expression of the Bcg gene in macrophages. Res Immunol 1989; 140:793-7.
22. Appelberg R, Sarmento AM. The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice. Clin Exp Immunol 1990; 80:324-31.
23. Schurr E, Malo D, Radzioch D et al. Genetic control of innate resistance to mycobacterial infections. Immunol Today 1991; 12:A42-45.
24. Vidal SM, Malo D, Vogan K et al. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993; 73:469-85.
25. Segal AW. Biochemistry and molecular biology of chronic granulomatous disease. J Inherit Metab Dis 1992; 15:683-6.
26. Pfeffer K, Matsuyama T, Kundig TM et al. Mice deficient for the 55kD tumor necrosis factor receptor are resistant to endotoxic shock yet succumb to L. monocytogenes infection. Cell 1994; 73:457-67.